FAR Biotech and Aragen Life Sciences Enter into a Collaboration to Advance Preclinical Program in Neurodegeneration

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): PR Newswire
  • Source:
    PR Newswire US. 05/30/2023.
  • Additional Information
    • Alternate Title:
      Aragen-FARBiotech
    • Abstract:
      Aragen will provide integrated drug discovery (IDD) services to support FAR Biotech's AI-driven, quantum biomodelling approach [ABSTRACT FROM PUBLISHER]